Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines of care for the management of atopic dermatitis in pediatric patients.

Journal of the American Academy of Dermatology·2026
Same author

Guidelines of care for the primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis.

Journal of the American Academy of Dermatology·2026
Same author

Focused update: Guidelines of care for the management of atopic dermatitis in adults.

Journal of the American Academy of Dermatology·2025
Same author

North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations.

Journal of the American Academy of Dermatology·2024
Same author

Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.

Journal of the American Academy of Dermatology·2023
Same author

Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.

Journal of the American Academy of Dermatology·2023
Same journal

<i>Letter:</i> Anogenital Dermatitis Rarely Occurs in Isolation: Disease Distribution and Delays in Patch Testing.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Practical Techniques: Photopatch Testing.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Digital Image Superimposition for Identifying Delayed Patch Test Reactions: A Clinical Pearl.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Analysis of Sulfite Concentrations in Common Beverages Consumed in the United States.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

<i>Letter:</i> Nickel Sensitization After Patent Foramen Ovale Closure.

Dermatitis : contact, atopic, occupational, drug·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Allergic contact dermatitis: the future.

Ali Alikhan1, Howard I Maibach

  • 1MacNeal Hospital, Berwyn, IL, USA.

Dermatitis : Contact, Atopic, Occupational, Drug
|December 5, 2009
PubMed
Summary
This summary is machine-generated.

Future directions in allergic contact dermatitis (ACD) involve refining diagnosis and management through advanced patch testing, better allergen identification, and novel in vitro diagnostics. Enhanced collaboration and specialized training are key to addressing complex ACD challenges.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Related Experiment Videos

Last Updated: Jun 18, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Area of Science:

  • Dermatology
  • Allergology
  • Immunology

Background:

  • Allergic Contact Dermatitis (ACD) has a foundational knowledge base from early discoveries.
  • Refinement of existing knowledge is crucial for advancing ACD diagnosis and management.
  • Current diagnostic and management strategies require further improvement.

Purpose of the Study:

  • To outline future directions for the diagnosis and management of Allergic Contact Dermatitis (ACD).
  • To identify key areas for research and development in ACD.
  • To emphasize the need for enhanced collaboration and education in contact allergy.

Main Methods:

  • Discussion of improvements in patch-test technology, strategy, and clinical relevance.
  • Emphasis on complete ingredient identification on Material Safety Data Sheets (MSDS).
  • Exploration of novel diagnostic methods including in vitro diagnostics, skin bioengineering, and ribonucleic acid (RNA) methods.

Main Results:

  • Potential for more precise and less invasive ACD diagnosis through new technologies.
  • Improved documentation and epidemiology of allergens via allergen banks and analytic chemistry labs.
  • Enhanced understanding of ACD's relationship with extracutaneous allergic diseases and evolutionary implications.

Conclusions:

  • Continued research and technological advancements are vital for precise ACD diagnosis.
  • International collaboration and data sharing are essential for allergen epidemiology.
  • Specialized training and fellowships are necessary to equip dermatologists for complex ACD cases.